Health and Healthcare

All Health and Healthcare Articles

Newest first · Page 101

Solid Breast Cancer Results From MacroGenics Ahead of ASCO

MacroGenics announced additional details of the results from the Phase 3 Sophia study of margetuximab in patients with HER2-positive metastatic breast cancer who have previously been treated with anti-HER2-targeted therapies.

Chris Lange · 8 years ago

Iovance Bio’s Big Break in Cervical Cancer Ahead of ASCO

Iovance Biotherapeutics is one of the early big winners from ASCO. The firm announced updates from ongoing clinical trials including new interim data from studies of patients with advanced cervical cancer and advanced melanoma.

Chris Lange · 8 years ago

Why Agilent Stock Plunged 12% After Earnings

Health care instrument maker Agilent is getting hammered Wednesday following a worse-than-expected earnings report for the company's second fiscal quarter. The company's outlook for the rest of the year made matters worse.

Paul Ausick · 8 years ago

The Best Biotech ETFs to Buy Ahead of ASCO

The 55th annual meeting of the American Society of Clinical Oncology (ASCO) is just around the corner. Biotech and pharmaceutical companies will descend on Chicago for a five-day all-out conference (May 31 to June…

Chris Lange · 8 years ago

Big Pharma Scares Off Short Sellers

The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.

Chris Lange · 8 years ago

Short Sellers Back Off Major Biotechs

The April 30 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks decreased.

Chris Lange · 8 years ago

What to Expect When Mylan Reports Tuesday

Mylan is scheduled to release its first-quarter financial results before the markets open on Tuesday, and earnings are expected to be lower than a year ago.

Chris Lange · 8 years ago